Clinical Trial

Subcutaneous Calcitonin in Acute Herpes Zoster

Name: Subcutaneous Calcitonin in Acute Herpes Zoster — clinical trial record (NCT07655804)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-07

Trial Details

NCT Number	NCT07655804
Lead Sponsor	Tanta University
Conditions	Calcitonin, Subcutaneous, Acute Herpes Zoster
Enrollment	168 participants
Start Date	2026-07-01
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-06